News
2021-12-20
In August 2018, Rejuven Dermaceutical was awarded the selective honor of “Hangzhou High-tech Enterprise” presented by Hangzhou Municipal Bureau of Science and Technology.
2021-12-20
On August 14, 2018 over 20 alumni from Fudan University who were working in Hangzhou paid a group visit to Rejuven. They learned about the development history, current key R & D projects and future plans of the company and provided constructive suggestions for the future growth of Rejuven.
2021-12-20
On June 11, 2018, Rejuven Dermaceutical was invited to present its new drug development and future business development in the third annual meeting of Suzhou New Drug Founder Club in Suzhou, Jiangsu Province.
2021-12-20
On April 18-20, 2018, Rejuven Dermaceutical was invited to present its new drug development program and future financial needs in the 2018 CHC-Citic Securities Medical Health Conference and the 7th CEO Summit of China Medical Health Industry Investment and Acquisition.
2021-12-20
In the end of 2017, Rejuven Dermaceutial was awarded the “Science and Technology Enterprises in Zhejiang Province”
2021-12-20
On November 30, 2016, Wuhan Rejuven Pharmaceutical Company,a wholly owned subsidiary of Hangzhou Rejuven Dermaceutical,was registered in Donghu New Technology Development Zone,Wuhan,Hubei Province.